These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10890475)

  • 1. Effects of hemofiltration on serum aprotinin levels in patients undergoing cardiopulmonary bypass.
    Van Norman GA; Patel MA; Chandler W; Vocelka C
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):253-6. PubMed ID: 10890475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery.
    Türköz A; Ciğli A; But K; Sezgin N; Türköz R; Gülcan O; Ersoy MO
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):603-10. PubMed ID: 11688002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic analysis and dosing regimen optimization of aprotinin in neonates and young infants undergoing cardiopulmonary bypass.
    Tae YM; Kwak JG; Kim BH; Jang IJ; Kim WH
    J Clin Pharmacol; 2011 Aug; 51(8):1163-76. PubMed ID: 20926755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
    Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of therapeutic plasma aprotinin levels during prolonged cardiopulmonary bypass using a large-dose regimen.
    Bennett-Guerrero E; Sorohan JG; Howell ST; Ayuso L; Cardigan RA; Newman MF; Mackie IJ; Reves JG; Mythen MG
    Anesth Analg; 1996 Dec; 83(6):1189-92. PubMed ID: 8942584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary bypass influences the plasma levels of calcitonin gene-related peptides in dogs: effects of hemofiltration and hemodilution.
    Isaka M; Imamura M; Sakuma I; Makino Y; Shiiya N; Yasuda K
    Res Vet Sci; 2007 Feb; 82(1):110-4. PubMed ID: 16839577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
    Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT
    Am J Nephrol; 2008; 28(4):576-82. PubMed ID: 18264006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and echocardiographic effects of hemofiltration performed during cardiopulmonary bypass.
    Blanchard N; Toque Y; Trojette F; Quintard JM; Benammar A; Montravers P
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):393-8. PubMed ID: 10972603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High oxygen concentration exacerbates cardiopulmonary bypass-induced lung injury.
    Pizov R; Weiss YG; Oppenheim-Eden A; Glickman H; Goodman S; Koganov Y; Barak V; Merin G; Kramer MR
    J Cardiothorac Vasc Anesth; 2000 Oct; 14(5):519-23. PubMed ID: 11052431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden does not affect bleeding in aprotinin recipients after cardiopulmonary bypass.
    Boehm J; Grammer JB; Lehnert F; Dietrich W; Wagenpfeil S; Wildhirt SM; Wottke M; Braun S; Lange R; Bauernschmitt R
    Anesthesiology; 2007 Apr; 106(4):681-6. PubMed ID: 17413905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of renal dysfunction on aprotinin pharmacokinetics during cardiopulmonary bypass.
    O'Connor CJ; Brown DV; Avramov M; Barnes S; O'Connor HN; Tuman KJ
    Anesth Analg; 1999 Nov; 89(5):1101-7. PubMed ID: 10553819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.